Thromboelastogram During Total Knee Replacement
Completed
- Conditions
- Orthopedic Procedures, Tranexamic Acid
- Registration Number
- NCT02373969
- Lead Sponsor
- Rambam Health Care Campus
- Brief Summary
Verify the changes in coagulation system during total knee replacement surgery with tranexamic acid single bolus infusion.
- Detailed Description
The study was set to reveal changes in the coagulation and fibrinolytic systems during total knee surgery and especially during tourniquet placement, tourniquet removal and revascularization of ischemic limb, after tranexamic acid single bolus infusion, and at post operative day 1.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Osteoarthrosis
- TKR operation elective
- ASA I-III
Exclusion Criteria
- TKR due to any reason but osteoarthrosis
- known coagulation problems
- platelets < 100,000/DcL
- Hb < 12 g%
- past thrombo-embolic event
- treatment with aspiring during last week
- treatment with NSAID's during last 48 hours
- malignancy
- known allergy to tranexamic acid
- general anesthesia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in coagulation status during and after surgery compared to pre-surgery During and after surgery compared to pre-surgery Change in fibrinolytic activity during and after surgery compared to pre-surgery During and after surgery compared to pre-surgery
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms explain coagulation changes observed in NCT02373969 total knee replacement study?
How does tranexamic acid compare to other antifibrinolytic agents in total knee arthroplasty outcomes?
Which coagulation biomarkers predict postoperative thromboembolic risk in knee replacement patients?
What are the long-term safety profiles of tranexamic acid in orthopedic surgery populations?
How do tourniquet-induced hemostatic changes interact with antifibrinolytic therapy in knee arthroplasty?